ArticleBMC plant biology2025
Comparative chloroplast genome analysis and phylogenomics of Nigerian Aframomum (Zingiberaceae): insights into chloroplast genome evolution and species divergence.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAframomum is a genus of ecologically and economically important plants in the Zingiberaceae family, yet its genomic evolution remains poorly understood. Previous chloroplast genome studies in the family have focused mainly on Asian genera such as Alpinia and Amomum, leaving the African lineage unexplored.
methodsThis study presents a comparative analysis of the complete chloroplast genomes of five Aframomum species, including A. alboviolaceum, A. angustifolium, A. daniellii, A. melegueta, and A. sceptrum. High-throughput Illumina sequencing was used to assemble the chloroplast genomes, which were annotated and analyzed for structural features, sequence divergence, codon usage, simple sequence repeats (SSRs), long repeats, and selection pressure on protein-coding genes. Phylogenetic relationships and divergence times were inferred using Bayesian methods implemented in MrBayes and BEAST2, respectively.
resultsAll five chloroplast genomes exhibited a conserved quadripartite structure with genome sizes ranging from 161,101 bp to 166,130 bp, but displayed lineage-specific variation at inverted repeat/single-copy boundaries, particularly the expanded ycf1 and rps19 gene junctions in A. alboviolaceum. Comparative analyses revealed high sequence conservation, with notable divergence hotspots in non-coding regions, including ycf1-rps15, atpH-atpI, and trnT-trnL. Codon usage patterns indicated strong AT-bias, and selection analyses revealed that most genes are under purifying selection, whereas ycf1, rpoC2, and rpl16 show signals of positive selection, suggesting adaptive evolution in photosynthetic and translational functions. SSR analysis revealed predominantly A/T-rich mononucleotide repeats, with slight interspecific variation. Phylogenomic analysis strongly supported the monophyly of Aframomum and its close relationship to Amomum. Divergence time estimation indicates that Aframomum began diversifying around 26 Mya, with major radiation during the Miocene, contemporaneous with the African climatic shift that likely drove speciation.
conclusionsThis study provides valuable insights into the chloroplast genome evolution and phylogeny of Aframomum, highlighting regions of high variability that are potential targets for molecular marker development. The results also reinforce the utility of chloroplast genome data in resolving evolutionary relationships and estimating divergence times within Zingiberaceae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.